221 related articles for article (PubMed ID: 19017754)
1. Effects of somatostatin analogs on a growth hormone-releasing hormone secreting bronchial carcinoid, in vivo and in vitro studies.
van Hoek M; Hofland LJ; de Rijke YB; van Nederveen FH; de Krijger RR; van Koetsveld PM; Lamberts SW; van der Lely AJ; de Herder WW; Feelders RA
J Clin Endocrinol Metab; 2009 Feb; 94(2):428-33. PubMed ID: 19017754
[TBL] [Abstract][Full Text] [Related]
2. Medical management of acromegaly due to ectopic production of growth hormone-releasing hormone by a carcinoid tumor.
Melmed S; Ziel FH; Braunstein GD; Downs T; Frohman LA
J Clin Endocrinol Metab; 1988 Aug; 67(2):395-9. PubMed ID: 2899089
[TBL] [Abstract][Full Text] [Related]
3. Ectopic growth hormone-releasing hormone secretion by a metastatic bronchial carcinoid tumor: a case with a non hypophysial intracranial tumor that shrank during long acting octreotide treatment.
Fainstein Day P; Frohman L; Garcia Rivello H; Reubi JC; Sevlever G; Glerean M; Fernandez Gianotti T; Pietrani M; Rabadan A; Racioppi S; Bidlingmaier M
Pituitary; 2007; 10(3):311-9. PubMed ID: 17373589
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin analogs in vitro effects in a growth hormone-releasing hormone-secreting bronchial carcinoid.
Zatelli MC; Maffei P; Piccin D; Martini C; Rea F; Rubello D; Margutti A; Culler MD; Sicolo N; degli Uberti EC
J Clin Endocrinol Metab; 2005 Apr; 90(4):2104-9. PubMed ID: 15671091
[TBL] [Abstract][Full Text] [Related]
5. Acromegaly due to a growth hormone-releasing hormone-secreting bronchial carcinoid tumor: further information on the abnormal responsiveness of the somatotroph cells and their recovery after successful treatment.
Boizel R; Halimi S; Labat F; Cohen R; Bachelot I
J Clin Endocrinol Metab; 1987 Feb; 64(2):304-8. PubMed ID: 3098773
[TBL] [Abstract][Full Text] [Related]
6. Acromegaly due to ectopic secretion of GHRH by bronchial carcinoid in a patient with empty sella.
Osella G; Orlandi F; Caraci P; Ventura M; Deandreis D; Papotti M; Bongiovanni M; Angeli A; Terzolo M
J Endocrinol Invest; 2003 Feb; 26(2):163-9. PubMed ID: 12739745
[TBL] [Abstract][Full Text] [Related]
7. The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro.
Hofland LJ; van der Hoek J; van Koetsveld PM; de Herder WW; Waaijers M; Sprij-Mooij D; Bruns C; Weckbecker G; Feelders R; van der Lely AJ; Beckers A; Lamberts SW
J Clin Endocrinol Metab; 2004 Apr; 89(4):1577-85. PubMed ID: 15070915
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and outcome of acromegaly induced by ectopic secretion of growth hormone-releasing hormone (GHRH): a French nationwide series of 21 cases.
Garby L; Caron P; Claustrat F; Chanson P; Tabarin A; Rohmer V; Arnault G; Bonnet F; Chabre O; Christin-Maitre S; du-Boullay H; Murat A; Nakib I; Sadoul JL; Sassolas G; Claustrat B; Raverot G; Borson-Chazot F;
J Clin Endocrinol Metab; 2012 Jun; 97(6):2093-104. PubMed ID: 22442262
[TBL] [Abstract][Full Text] [Related]
9. Acromegaly due to GHRH-secreting large bronchial carcinoid. Complete recovery following tumor surgery.
Bolanowski M; Schopohl J; Marciniak M; Rzeszutko M; Zatonska K; Daroszewski J; Milewicz A; Malczewska J; Badowski R
Exp Clin Endocrinol Diabetes; 2002 Jun; 110(4):188-92. PubMed ID: 12058343
[TBL] [Abstract][Full Text] [Related]
10. The somatostatin analogue SOM230, compared with octreotide, induces differential effects in several metabolic pathways in acromegalic patients.
van der Hoek J; van der Lelij AJ; Feelders RA; de Herder WW; Uitterlinden P; Poon KW; Boerlin V; Lewis I; Krahnke T; Hofland LJ; Lamberts SW
Clin Endocrinol (Oxf); 2005 Aug; 63(2):176-84. PubMed ID: 16060911
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.
Gola M; Doga M; Bonadonna S; Mazziotti G; Vescovi PP; Giustina A
Pituitary; 2006; 9(3):221-9. PubMed ID: 17036195
[TBL] [Abstract][Full Text] [Related]
12. [Five year remission of GHRH secreting bronchial neuroendocrine tumor with symptoms of acromegaly. Utility of chromogranin A in the monitoring of the disease].
Bolanowski M; Kos-Kudła B; Rzeszutko M; Marciniak M; Zatońska K
Endokrynol Pol; 2006; 57(1):32-6. PubMed ID: 16575760
[TBL] [Abstract][Full Text] [Related]
13. [Acromegaly and bronchial carcinoid tumor. Apropos of a case].
Caron P; Guittard J; Trouillas J; Salvador M; Bayard F
Ann Endocrinol (Paris); 1992; 53(4):158-61. PubMed ID: 1305802
[TBL] [Abstract][Full Text] [Related]
14. Long-acting lanreotide induces clinical and biochemical remission of acromegaly caused by disseminated growth hormone-releasing hormone-secreting carcinoid.
Drange MR; Melmed S
J Clin Endocrinol Metab; 1998 Sep; 83(9):3104-9. PubMed ID: 9745411
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous octreotide treatment of a growth hormone-releasing hormone-secreting bronchial carcinoid: superiority of continuous versus intermittent administration to control hormonal secretion.
Lefebvre S; De Paepe L; Abs R; Rahier J; Selvais P; Maiter D
Eur J Endocrinol; 1995 Sep; 133(3):320-4. PubMed ID: 7581949
[TBL] [Abstract][Full Text] [Related]
16. Acromegaly due to ectopic growth hormone-releasing hormone secretion by a bronchial carcinoid tumour. Dynamic hormonal responses to various stimuli.
Glikson M; Gil-Ad I; Galun E; Dresner R; Zilberman S; Halperin Y; Okon E; Laron Z; Rubinow A
Acta Endocrinol (Copenh); 1991 Oct; 125(4):366-71. PubMed ID: 1683501
[TBL] [Abstract][Full Text] [Related]
17. Acromegaly caused by ectopic growth hormone-releasing hormone production from a bronchial carcinoid tumor.
Gudbjartsson T; Agnarsson BA; Palsson PS; Johannesson A
Thorac Cardiovasc Surg; 2011 Apr; 59(3):184-5. PubMed ID: 21480145
[TBL] [Abstract][Full Text] [Related]
18. A single-dose comparison of the acute effects between the new somatostatin analog SOM230 and octreotide in acromegalic patients.
van der Hoek J; de Herder WW; Feelders RA; van der Lely AJ; Uitterlinden P; Boerlin V; Bruns C; Poon KW; Lewis I; Weckbecker G; Krahnke T; Hofland LJ; Lamberts SW
J Clin Endocrinol Metab; 2004 Feb; 89(2):638-45. PubMed ID: 14764775
[TBL] [Abstract][Full Text] [Related]
19. Acromegaly due to ectopic growth hormone (GH)-releasing hormone (GHRH) production: dynamic studies of GH and ectopic GHRH secretion.
Barkan AL; Shenker Y; Grekin RJ; Vale WW; Lloyd RV; Beals TF
J Clin Endocrinol Metab; 1986 Nov; 63(5):1057-64. PubMed ID: 3093517
[TBL] [Abstract][Full Text] [Related]
20. SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile.
Bruns C; Lewis I; Briner U; Meno-Tetang G; Weckbecker G
Eur J Endocrinol; 2002 May; 146(5):707-16. PubMed ID: 11980628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
